RNA Formulation Resources
-
Where Innovation Is Moving The Advanced Therapies Supply Chain
4/28/2026
Assimilate how advanced therapy supply chains are evolving toward patient-centric, risk-managed, digitally connected models to support scale, reliability, and regulatory confidence globally today.
-
Outsourcing RNA-LNP Production: A Key To Competitive Success
3/6/2025
Manufacturing RNA-containing LNPs demands specialized expertise. Explore some of the challenges of RNA-LNP drug manufacturing and the advantages of outsourcing RNA-LNP formulations.
-
Leveraging Single-Use Technology For mRNA-LNP Drug Manufacturing
6/12/2023
Single-use technology is vital for ensuring the quality and expedited market entry of genomic medicines. Learn how LNP technology is paving the way for a new era of personalized, precise medicine.
-
Safe, Scalable And GMP-Ready DNA
4/24/2026
Cell‑free synthetic DNA provides a scalable, safer alternative to plasmids by eliminating bacterial risks, simplifying quality control, and enabling complex sequences under GMP‑aligned conditions.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Precision In Nanoparticle Processing And Monodispersed Lipid Nanoparticles For Advanced Therapeutics
11/17/2025
Precision in nanoparticle processing is key for drug delivery and vaccines. Learn how monodispersed formulations enhance reproducibility and stability for next-generation therapeutics, like RNA-LNPs.
-
Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products
10/24/2025
Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.
-
Recommendations For Successful IND Approval Of RNA-LNP Drugs
8/22/2023
The existing regulatory system is ambiguous for RNA therapeutics. Leverage this Investigational New Drug (IND) guide to help accelerate and strengthen the process IND filing of novel nanomedicines.
-
LNP Formulation For mRNA Delivery
2/15/2023
Microfluidic mixing is one of the most effective means to formulate LNPs for its scalability and reproducibility. Explore LNP formulation, polishing, sterile filtration of mRNA-LNPs, and more.
-
Accelerate LNP Manufacturing With Automated Process Development
2/5/2026
Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.